Show simple item record

dc.contributor.advisorAyata, Ali
dc.contributor.advisorÖzen, Metehan
dc.contributor.authorKendir Demirkol, Yasemin
dc.date.accessioned2020-12-10T11:57:36Z
dc.date.available2020-12-10T11:57:36Z
dc.date.submitted2011
dc.date.issued2018-08-06
dc.identifier.urihttps://acikbilim.yok.gov.tr/handle/20.500.12812/272291
dc.description.abstractBu çalışmada linezolid ile oluşturulan oksidatif stres ve yan etkilere karşı piridoksinin koruyucu etkisi araştırıldı. Bu amaçla 40 erkek Spraque-Dawley cinsi rat alınarak dört grup oluşturuldu. Kontrol grubuna (K, n:10) 1 mL serum fizyolojik, linezolid grubuna (L, n:10) 125 mg/kg/gün linezolid, piridoksin grubuna (P, n:10) 100 mg/kg/gün piridoksin, linezolid+piridoksin grubuna (LP, n:10) ise 125 mg/kg/gün linezolid ve 100 mg/kg/gün piridoksin, 14 gün boyunca gavaj yoluyla uygulandı.İlaç uygulama öncesinde ve sonrasında kan örnekleri alınarak tam kan sayımı, BUN, kreatinin, alanin amino transferaz (ALT), aspartat amino transferaz (AST), total ve direkt bilirübin değerlerine bakıldı. Eritrositlerde glutatyon peroksidaz (GSH-Px), süperoksit dismutaz (SOD), katalaz (CAT) aktiviteleri ile malondialdehit (MDA) düzeyi ölçüldü.Deney sonunda; linezolidin lökosit sayısında azalmaya, serum ALT düzeyinde yükselmeye yol açtığı, SOD, GSH-Px, CAT enzim aktivitelerini ve MDA düzeyini yükselttiği gözlendi (p<0.05). Piridoksinin ise, linezolidin yol açtığı lökopeni ve ALT yükselmesine karşı koruyucu etkisi olmadığı, ancak antioksidan enzim aktivitesini ve MDA düzeyini düşürerek, eritrositlerde gelişen oksidatif hasarı önlediği tespit edildi (p<0.05).Anahtar Kelimeler: Linezolid, oksidatif stres, piridoksin, rat, yan etki
dc.description.abstractIn this study we was evaluated the protective effects of pyridoxine againts linezolide-induced hematological side effects and oxidative stress in rats. For this purpose, 40 male Spraque Dawley rats were used and divided into four groups. The control group (K, n:10) was administered 1 mL of saline solution, the linezolid group (L, n:10) was administered 125 mg/kg/day of linezolid, the pyridoxine group (P, n:10) was administered 100 mg/kg/day of pyridoxine, and the linezolid+pyridoxine group (LP, n:10) was administered 125 mg/kg/day of linezolid and 100 mg/kg/day pyridoxine for 14 days by gavage.Before and after the drug administration period, blood samples were collected to measure complete blood count, BUN, creatinine, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total and direct bilirubin values. Glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase (CAT) activities, and malondialdehyde (MDA) levels were measured in the erythrocytes.At the end of the study, leukocyte count was decreased, levels of MDA and ALT levels and activities of SOD, GSH-Px, CAT were increased significantly in the linezolid group compared to the control and LP groups (p<0.05). It was also found that pyridoxine had no protective effects on linezolid-induced leukopenia and increased ALT level. These results suggest that pyridoxine can protect the oxidative stress that occurs in the erythrocytes reducing by antioxidant enzyme activity and MDA levels caused by linezolid (p<0.05).Keywords: Linezolid, oxidative stress, pyridoxine, rat, side effecten_US
dc.languageTurkish
dc.language.isotr
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAttribution 4.0 United Statestr_TR
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectÇocuk Sağlığı ve Hastalıklarıtr_TR
dc.subjectChild Health and Diseasesen_US
dc.titleLinezolid ile oluşturulan oksidatif stres ve hematolojik yan etkilere karşı piridoksinin koruyucu etkilerinin araştırılması
dc.title.alternativeProtective Effects of Pyridoxine Against Oxidative Stress and Hematologic Side Effect of Linezolid
dc.typedoctoralThesis
dc.date.updated2018-08-06
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Anabilim Dalı
dc.subject.ytmAnti infective agents
dc.subject.ytmOxidative stress
dc.subject.ytmHematology
dc.subject.ytmVitamin B 6
dc.subject.ytmRats
dc.subject.ytmComplications
dc.identifier.yokid404765
dc.publisher.instituteTıp Fakültesi
dc.publisher.universitySÜLEYMAN DEMİREL ÜNİVERSİTESİ
dc.type.submedicineThesis
dc.identifier.thesisid352768
dc.description.pages64
dc.publisher.disciplineDiğer


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess